Radó J P, Juhos E
Endokrinologie. 1976 Jul;67(3):377-9.
Potassium excretion was enhanced by spironolactone and it was inhibited by amiloride in a patient with ascites. One drug's effect was counteracted by the other when they were used in combination. Individual variation in the sites of action of antikaluretic drugs might be a possible explanation for the unpredictable changes in potassium excretion induced by these agents.
在一名腹水患者中,螺内酯可增强钾排泄,而氨氯吡咪则抑制钾排泄。当联合使用这两种药物时,一种药物的作用会被另一种药物抵消。抗利尿药物作用部位的个体差异可能是这些药物引起钾排泄不可预测变化的一个可能解释。